Health Condition 1: null- Patients undergoing total laparoscopic hystrectomy under general anaesthesia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ASA I or ASA II patients undergoing laparoscopic hysterectomy
Exclusion criteria
Exclusion criteria: • Inability to provide informed consent • Refusal for spinal anaesthesia • Morbid obesity • Coagulation disorders or treatment with anticoagulants • Severe spinal deformities • Infection at the injection site • Symptomatic cardiac and respiratory disease • Chronic analgesic use • Not capable of understanding PCA device use • Undergoing concurrent laparoscopic procedures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To determine the efficacy of intrathecal morphine for perioperative analgesia in patients undergoing total laparoscopic hysterectomy by its effect on VAS. 2. To assess the effect of intrathecal morphine on perioperative endocrine stress markers compared with fentanyl infusion.Timepoint: 1.The first pain assessment was done as soon as the patient was awake, oriented and capable of following commands. VAS scoring was done 2-hourly for 8 hours and at 24 hours. 2.Blood samples for stress markers were taken 8 a.m one day prior to surgery , half an hour after initiation of pneumoperitoneum and one hour after the end of surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To assess perioperative opioid sparing effect of intrathecal morphineTimepoint: 24 hours | — |
Countries
India
Contacts
All India institute of medical sciences